venetoclax-话题@MedSci

#venetoclax#

2篇内容 | 1694人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2199619, encodeId=f033219961929, content=<a href='/topic/show?id=96129e81891' target=_blank style='color:#2F92EE;'>#阿扎胞苷#</a> <a href='/topic/show?id=eb2152482d7' target=_blank style='color:#2F92EE;'>#急性髓系白血病#</a> <a href='/topic/show?id=ed2a183e6ce' target=_blank style='color:#2F92EE;'>#venetoclax#</a>, objectTitle=Lancet Haematol：小剂量阿扎胞苷加venetoclax作为急性髓系白血病强化或低强度诱导后的维持治疗, objectType=article, longId=822640, objectId=db7b822640af, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696890457657_4754896.jpeg, objectUrl=/article/show_article.do?id=db7b822640af, replyNumber=0, likeNumber=92, createdTime=2024-04-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=db7b822640af, moduleTitle=Lancet Haematol：小剂量阿扎胞苷加venetoclax作为急性髓系白血病强化或低强度诱导后的维持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db7b822640af)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2194228, encodeId=e6572194228b0, content=<a href='/topic/show?id=ed2a183e6ce' target=_blank style='color:#2F92EE;'>#venetoclax#</a> <a href='/topic/show?id=1ba63e26086' target=_blank style='color:#2F92EE;'>#去甲基化药物#</a> <a href='/topic/show?id=7b468016366' target=_blank style='color:#2F92EE;'>#老年急性髓系白血病#</a> <a href='/topic/show?id=98ef112469b8' target=_blank style='color:#2F92EE;'>#系统性综述和荟萃分析#</a>, objectTitle=Eur Rev Med Pharmacol Sci：venetoclax联合去甲基化药物治疗老年急性髓系白血病的疗效和安全性：系统性综述和荟萃分析, objectType=article, longId=817526, objectId=83c681e5268c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668018121539_4754896.png, objectUrl=/article/show_article.do?id=83c681e5268c, replyNumber=1, likeNumber=62, createdTime=2024-03-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=83c681e5268c, moduleTitle=Eur Rev Med Pharmacol Sci：venetoclax联合去甲基化药物治疗老年急性髓系白血病的疗效和安全性：系统性综述和荟萃分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83c681e5268c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1241613, encodeId=a36c124161332, content=<a href='/topic/show?id=ed2a183e6ce' target=_blank style='color:#2F92EE;'>#venetoclax#</a>联合<a href='/topic/show?id=2d4c4140296' target=_blank style='color:#2F92EE;'>#地西他滨#</a>10日疗法治疗各种<a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a>亚型的疗效, objectTitle=Lancet Haematol：Venetoclax联合地西他滨10日疗法治疗各种AML亚型的疗效, objectType=article, longId=200385, objectId=776020038565, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202097/1599469822216_2110107.PNG, objectUrl=/article/show_article.do?id=776020038565, replyNumber=0, likeNumber=131, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=776020038565, moduleTitle=Lancet Haematol：Venetoclax联合地西他滨10日疗法治疗各种AML亚型的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=776020038565)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=904224, encodeId=e42a904224b6, content=<a href='/topic/show?id=5be526941ee' target=_blank style='color:#2F92EE;'>#依鲁替尼#</a>和<a href='/topic/show?id=ed2a183e6ce' target=_blank style='color:#2F92EE;'>#venetoclax#</a>连用，可治疗复发/难治性<a href='/topic/show?id=bde45355068' target=_blank style='color:#2F92EE;'>#慢性淋巴细胞白血病#</a>, objectTitle=JCO：依鲁替尼和Venetoclax连用，可治疗复发/难治性慢性淋巴细胞白血病, objectType=article, longId=175433, objectId=30531e5433ab, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201907/20190714152124289.png, objectUrl=/article/show_article.do?id=30531e5433ab, replyNumber=0, likeNumber=234, createdTime=2020-12-02, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30531e5433ab, moduleTitle=JCO：依鲁替尼和Venetoclax连用，可治疗复发/难治性慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30531e5433ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

venetoclax

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#阿扎胞苷# #急性髓系白血病# #venetoclax#

Lancet Haematol：小剂量阿扎胞苷加venetoclax作为急性髓系白血病强化或低强度诱导后的维持治疗

2024-04-21发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#venetoclax# #去甲基化药物# #老年急性髓系白血病# #系统性综述和荟萃分析#

Eur Rev Med Pharmacol Sci：venetoclax联合去甲基化药物治疗老年急性髓系白血病的疗效和安全性：系统性综述和荟萃分析

2024-03-20发表于上海

循证小兵 (审核中...)

前往app查看评论内容

#venetoclax#联合#地西他滨#10日疗法治疗各种#AML#亚型的疗效

Lancet Haematol：Venetoclax联合地西他滨10日疗法治疗各种AML亚型的疗效

2022-08-28

lovetcm (审核中...)

前往app查看评论内容

#依鲁替尼#和#venetoclax#连用，可治疗复发/难治性#慢性淋巴细胞白血病#

JCO：依鲁替尼和Venetoclax连用，可治疗复发/难治性慢性淋巴细胞白血病

2020-12-02

科室
- - 订阅+
  - 更多科室
工具
服务